Abstract
Telomeres, the nucleoprotein complexes located at the ends of chromosomes, are involved in chromosome protection and genome stability. Telomeric repeat binding factor 1 (TRF1) and telomeric repeat binding factor 2 (TRF2) are the two telomeric proteins that bind to duplex telomeric DNA through interactions between their C-terminal domain and several guanines of the telomeric tract. Since the antitumour drug cisplatin binds preferentially to two adjacent guanines, we have investigated whether cisplatin adducts could affect the binding of TRF1 and TRF2 to telomeric DNA and the property of TRF2 to stimulate telomeric invasion, a process that is thought to participate in the formation of the t-loop. We show that the binding of TRF1 and TRF2 to telomeric sequences selectively modified by one GG chelate of cisplatin is markedly affected by cisplatin but that the effect is more drastic for TRF2 than for TRF1 (3–5-fold more sensitivity for TRF2 than for TRF1). We also report that platinum adducts cause a decrease in TRF2-dependent stimulation of telomeric invasion in vitro. Finally, in accordance with in vitro data, analysis of telomeric composition after cisplatin treatment reveals that 60% of TRF2 dissociate from telomeres.
Similar content being viewed by others
References
Autexier C, Lue NF (2006) Annu Rev Biochem 75:493–517
Chong L, van Steensel B, Broccoli D, Erdjument Bromage H, Hanish J, Tempst P, de Lange T (1995) Science 270:1663–1667
Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E (1997) Nat Genet 17:236–239
Broccoli D, Smogorzewska A, Chong L, de Lange T (1997) Nat Genet 17:231–235
Baumann P, Cech TR (2001) Science 292:1171–1175
De Lange T (2005) Cold Spring Harb Symp Quant Biol 70:197–204
Liu D, O’Connor MS, Qin J, Songyang Z (2004) J Biol Chem 279:51338–51342
Xin H, Liu D, Songyang Z (2008) Genome Biol 9:232
Smogorzewska A, de Lange T (2004) Annu Rev Biochem 73:177–208
Gilson E, Geli V (2007) Nat Rev Mol Cell Biol 8:825–838
van Steensel B, de Lange T (1997) Nature 385:740–743
Loayza D, De Lange T (2003) Nature 423:1013–1018
Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson E (2002) Mol Cell Biol 22:3474–3487
Karlseder J, Kachatrian L, Takai H, Mercer K, Hingorani S, Jacks T, de Lange T (2003) Mol Cell Biol 23:6533–6541
Iwano T, Tachibana M, Reth M, Shinkai Y (2004) J Biol Chem 279:1442–1448
van Steensel B, Smogorzewska A, de Lange T (1998) Cell 92:401–413
Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T (2000) Mol Cell Biol 20:1659–1668
Wang RC, Smogorzewska A, de Lange T (2004) Cell 119:355–368
Munoz P, Blanco R, Blasco MA (2006) Cell Cycle 5:718–721
Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T (1999) Science 283:1321–1325
Karlseder J, Smogorzewska A, de Lange T (2002) Science 295:2446–2449
Munoz P, Blanco R, Flores JM, Blasco MA (2005) Nat Genet 37:1063–1071
Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E, Koering CE, Gilson E (2003) Clin Cancer Res 9:1105–1111
Blasco MA (2005) Nat Rev Genet 6:611–622
Brunori M, Mathieu N, Ricoul M, Bauwens S, Koering CE, Roborel de Climens A, Belleville A, Wang Q, Puisieux I, Decimo D, Puisieux A, Sabatier L, Gilson E (2006) Oncogene 25:990–997
Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T (1999) Cell 97:503–514
Amiard S, Doudeau M, Pinte S, Poulet A, Lenain C, Faivre-Moskalenko C, Angelov D, Hug N, Vindigni A, Bouvet P, Paoletti J, Gilson E, Giraud-Panis MJ (2007) Nat Struct Mol Biol 14:147–154
Bilaud T, Koering CE, Binet Brasselet E, Ancelin K, Pollice A, Gasser SM, Gilson E (1996) Nucleic Acids Res 24:1294–1303
Bianchi A, Smith S, Chong L, Elias P, de Lange T (1997) EMBO J 16:1785–1794
Konig P, Fairall L, Rhodes D (1998) Nucleic Acids Res 26:1731–1740
Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, de Lange T (1999) EMBO J 18:5735–5744
Court R, Chapman L, Fairall L, Rhodes D (2005) EMBO Rep 6:39–45
Nishikawa T, Nagadoi A, Yoshimura S, Aimoto S, Nishimura Y (1998) Structure 6:1057–1065
Nishikawa T, Okamura H, Nagadoi A, Konig P, Rhodes D, Nishimura Y (2001) Structure 9:1237–1251
Bilbille Y, Paquet F, Meudal H, Giraud-Panis MJ, Lancelot G (2006) C R Chim 9:452–458
Heringova P, Kasparkova J, Brabec V (2009) J Biol Inorg Chem 14:959–968
Tahara H, Shin-Ya K, Seimiya H, Yamada H, Tsuruo T, Ide T (2006) Oncogene 25:1955–1966
Biroccio A, Rizzo A, Elli R, Koering CE, Belleville A, Benassi B, Leonetti C, Stevens MF, D’Incalci M, Zupi G, Gilson E (2006) Eur J Cancer 42:1881–1888
Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467–2498
Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307–320
Brabec V, Kasparkova J (2005) Drug Resist Updat 8:131–146
Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ (2000) Nucleic Acids Res 28:4237–4243
Ishibashi T, Lippard SJ (1998) Proc Natl Acad Sci USA 95:4219–4223
Zhang RG, Zhang RP, Wang XW, Xie H (2002) Cell Res 12:55–62
Jeyapalan JC, Saretzki G, Leake A, Tilby MJ, von Zglinicki T (2006) Int J Cancer 118:2727–2734
Ourliac-Garnier I, Charif R, Bombard S (2009) In: Hadjiliadis N, Sletten E (eds) Metal complexes–DNA interactions. Wiley–Blackwell, Oxford, pp 209–234
Redon S, Bombard S, Elizondo-Riojas MA, Chottard JC (2003) Nucleic Acids Res 31:1605–1613
Colangelo D, Osella D (2005) Curr Med Chem 12:3091–3102
Gonnet F, Kocher F, Blais JC, Bolbach G, Tabet JC (1996) J Mass Spectrom 31:802–809
Reeder F, Kozelka J, Chottard JC (1996) Inorg Chem 35:1413–1415
Ourliac-Garnier I, Elizondo-Riojas MA, Redon S, Farrell NP, Bombard S (2005) Biochemistry 44:10620–10634
LeRoy AF, Wehling ML, Sponseller HL, Friauf WS, Solomon RE, Dedrick RL, Litterst CL, Gram TE, Guarino AM, Becker DA (1977) Biochem Med 18:184–191
Gomez D, Wenner T, Brassart B, Douarre C, O’Donohue MF, El Khoury V, Shin-Ya K, Morjani H, Trentesaux C, Riou JF (2006) J Biol Chem 38721–38729
Fourrier L, Brooks P, Malinge JM (2003) J Biol Chem 278:21267–21275
Nishikawa T, Okamura H, Nagadoi A, Koig P, Rhodes D, Nishimura Y (2001) Nucleic Acids Res Suppl 273–274
Hanaoka S, Nagadoi A, Nishimura Y (2005) Protein Sci 14:119–130
Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ (1995) Nature 377:649–652
Gonnet F, Reeder F, Kozelka J, Chottard JC (1996) Inorg Chem 35:1653–1658
Legendre F, Bas V, Kozelka J, Chottard JC (2000) Chem Eur J 6:2002–2010
Opresko PL, Fan J, Danzy S, Wilson DM 3rd, Bohr VA (2005) Nucleic Acids Res 33:1230–1239
Acknowledgments
This work was supported by the Association pour la Recherche sur le Cancer (ARC grant 4835) for the S.B. team and La Ligue Contre le Cancer, Équipe Labelisée for the E.G. team. We also thank COST D39-0004-06 for financial support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ourliac-Garnier, I., Poulet, A., Charif, R. et al. Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1. J Biol Inorg Chem 15, 641–654 (2010). https://doi.org/10.1007/s00775-010-0631-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-010-0631-4